Cell Delivery and Mechanisms of Action of Antisense Oligonucleotides
Authors:
- Geneviève DegolsGDGeneviève Degols
- Jean Pierre ClarencJCJean Pierre Clarenc
- Nadir MechtiNMNadir Mechti
- Bernard LebleuBLBernard Lebleu
- 1 January 1993
- book chapter
- Published by Elsevier
- Vol. 44, 143-166
Abstract
No abstract availableThis publication has 67 references indexed in Scilit:
- Antisense inhibitors of HIV: Problems and perspectivesAntiviral Research, 1992
- DNA/RNA synthesis and labellingCurrent Opinion in Biotechnology, 1991
- Sequence-selective DNA recognition by synthetic ligandsBioconjugate Chemistry, 1991
- Demonstration in living cells of an intragenic negative regulatory element within the rodent c-fos geneCell, 1990
- Inhibition of Human Immunodeficiency Virus Type 1-mediated Cytopathic Effects by Poly(L-lysine)-conjugated Synthetic Antisense OligodeoxyribonucleotidesJournal of General Virology, 1989
- Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′‐terminus and their interaction with DNA within mammalian cellsFEBS Letters, 1989
- Antisense “Pseudogenetics”Cell Motility, 1989
- Antiviral activity in L1210 cells of liposome‐encapsulated (2′‐5′)oligo(adenylate) analoguesEuropean Journal of Biochemistry, 1985
- Production of phenocopies by Krüppel antisense RNA injection into Drosophila embryosNature, 1985
- FORMATION OF A THREE-STRANDED POLYNUCLEOTIDE MOLECULEJournal of the American Chemical Society, 1957